Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL188105 | 0.97 | — | — | |
| SCHEMBL43232 | 0.97 | — | — | |
| SCHEMBL8768172 | 0.97 | FFAR3 (0.35) | FOLH1NAALAD2GABRR1FFAR3CYP1A2 | |
| SCHEMBL29396747 | 0.97 | FFAR3 (0.35) | FOLH1NAALAD2GABRR1FFAR3CYP1A2 | |
| SCHEMBL3860250 | 0.97 | — | — | |
| SCHEMBL11607991 | 0.94 | FOLH1 (0.33) | FOLH1NAALAD2GABRR1FFAR3CYP1A2 | |
| L-Lactic Acid SCHEMBL31285806 | 0.87 | TP53 (0.52) | FOLH1NAALAD2GABRR1CYP1A2TSHR | |
| SCHEMBL108300 | 0.82 | TSHR (0.41) | FOLH1NAALAD2GABRR1FFAR3CYP1A2 | |
| 2-Oxoisohexanoate SCHEMBL25436317 | 0.82 | CA2 (0.38) | ALDH1A1 | |
| SCHEMBL3755021 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105121433-B | Antiviral compound, its pharmaceutically acceptable salt or optical isomer, the method for preparing them and the pharmaceutical composition for being used to prevent or treat viral disease for containing the same as active ingredient | 韩国化学研究院 | 2018-01-23 | — | — | CN | disclosed |
| CN-105121433-A | Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient | KOREA RES INST CHEM TECH | 2015-12-02 | — | — | CN | disclosed |
| CN-104781213-A | Pressure process | WZR ceramic solutions GmbH | 2015-07-15 | — | — | CN | disclosed |